The role of microRNAs as new anti-inflammatory targets for the treatment of asthma

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/510714

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Asthma is a significant health and economic burden to our society and its prevalence has increased over the last 25 years. New ways of treating asthma are urgently required as current therapeutics treat the symptoms and not the cause of the disease. Asthma is widely thought to be due to the abnormal accumulation of white blood cells (inflammation) in the lungs of diseased individuals. In this project we are exploring new advanced ways to inhibit inflammation and the development of disease.

Funded Activity Details

Start Date: 01-01-2008

End Date: 01-01-2012

Funding Scheme: NHMRC Project Grants

Funding Amount: $625,655.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Respiratory Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

acute and chronic inflammation | airways inflammation | asthma | asthma and allergy | chronic inflammation | inflammatory mediators | respiratory allergy

Related Links